Proton pump inhibitors use and risk of preeclampsia

Salman Hussain, Ambrish Singh, Benny Antony, Jitka Klugarová, Miloslav Klugar
doi: https://doi.org/10.1101/2021.09.15.21263602

Article Information

doi 
https://doi.org/10.1101/2021.09.15.21263602
History 
  • September 20, 2021.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.

Author Information

  1. Salman Hussain1,
  2. Ambrish Singh2,
  3. Benny Antony2,
  4. Jitka Klugarová1 and
  5. Miloslav Klugar1,*
  1. 1Czech National Centre for Evidence-Based Healthcare and Knowledge Translation, (Cochrane Czech Republic, Czech EBHC: JBI Centre of Excellence, Masaryk University GRADE Centre), Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Brno, Czech Republic
  2. 2Menzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania, Australia
  1. ↵*Corresponding author: Dr. Miloslav Klugar, E-mail: klugar{at}med.muni.cz, Czech National Centre for Evidence-Based Healthcare and Knowledge Translation, (Cochrane Czech Republic, Czech EBHC: JBI Centre of Excellence, Masaryk University GRADE Centre), Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Brno, Czech Republic
Back to top
Posted September 20, 2021.
Download PDF
Data/Code
Email
Proton pump inhibitors use and risk of preeclampsia
Salman Hussain, Ambrish Singh, Benny Antony, Jitka Klugarová, Miloslav Klugar
medRxiv 2021.09.15.21263602; doi: https://doi.org/10.1101/2021.09.15.21263602
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area